Cosmos Health Inc. (COSM)

Market Cap	11.72M
Revenue (ttm)	54.43M
Net Income (ttm)	-22.38M
Shares Out	27.20M
EPS (ttm)	-1.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	536,253
Open	0.4100
Previous Close	0.4219
Day's Range	0.4042 - 0.4355
52-Week Range	0.2800 - 1.5800
Beta	4.30
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 16, 2025

About COSM

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltu...

• Industry: Medical Distribution
• Sector: Healthcare
• IPO Date: Dec 13, 2013
• Employees: 149
• Stock Exchange: NASDAQ
• Ticker Symbol: COSM
• Website: https://www.cosmosholdingsinc.com

Financial Performance

In 2024, Cosmos Health's revenue was $54.43 million, an increase of 1.97% compared to the previous year's $53.38 million. Losses were -$22.38 million, -13.21% less than in 2023.